摘要
目的:促进乳腺癌术后化疗期间辅助药物的合理使用。方法:依据乳腺癌化疗期间辅助药物使用专家共识及循证医学证据,对某三级医院2014年5月-2015年4月129例乳腺癌患者术后化疗期间辅助药物的使用情况进行评价。结果:在止吐、保肝、抗肿瘤中成药、保护心脏及出血性膀胱炎预防等药物的使用上存在一些不规范处。结论:通过对乳腺癌术后化疗期间辅助药物使用分析,发现不合理使用情况,以促进临床合理用药。
OBJECTIVE To promote rational use of adjuvant drugs in patients with breast cancer during postoperative chemotherapy.METHODS According to some established specialist consensus about use of adjuvant drugs during chemotherapy and evidence based medicine,a retrospective drug use evaluation method was conducted to assess quality of adjuvant drugs prescribing in 129 patients after dissection of breast cancer from May,2014 to April,2015 in a third class hospital.RESULTSSome adjuvant drugs were not used rationally,such as antiemetic,liver protecting drugs,anticancer Chinese patent medicine,heart guarding drugs and hemorrhagic cystitis preventing drugs.CONCLUSION Irrational drug use can be found out by analyzing use of adjuvant drugs in patients with breast cancer during postoperative chemotherapy to finally promote rational use of drugs.
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
2016年第18期1574-1578,共5页
Chinese Journal of Hospital Pharmacy
基金
苏州药学会-常州四药临床药学会科研基金(编号:SYSD2014145)
关键词
乳腺癌
术后化疗
辅助药物
评价
合理用药
breast cancer
postoperative chemotherapy
adjuvant drugs
evaluation
rational use of drugs
